Caitong International Asset Management’s AngioDynamics ANGO Stock Holding History

Caitong International Asset Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$247	Sell	19 -2	-10%	-$23	﹤0.01%	1948
2026 Q1	$239	Sell	21 -8	-28%	-$87	﹤0.01%	1843
2025 Q4	$372	Sell	29 -169	-85%	-$2.09K	﹤0.01%	1521
2025 Q3	$2.21K	Buy	+198	New	+$1.91K	﹤0.01%	1367
2025 Q2	–	Sell	-434	Closed	-$4.08K	–	1976
2025 Q1	$4.08K	Buy	434 +336	+343%	+$3.53K	﹤0.01%	1082
2024 Q4	$898	Buy	+98	New	+$721	﹤0.01%	1355

Other funds holding ANGO

Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

PFC

Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

MNBTD

Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return

Caitong International Asset Management's ANGO Position: Q2 2026 in Review

Caitong International Asset Management reduced its AngioDynamics (ANGO) stake by 9.5% in Q2 2026, selling an estimated $23 and leaving 19 shares worth $247. The position accounts for ﹤0.01% of the portfolio, ranked #1948.

Caitong International Asset Management first reported a position in ANGO in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.08K in Q1 2025. 37 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

Caitong International Asset Management held 19 shares of AngioDynamics worth $247 as of Q2 2026.
Caitong International Asset Management sold 2 AngioDynamics shares in Q2 2026, an estimated $23.
AngioDynamics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1948 holding.
Caitong International Asset Management first reported a position in AngioDynamics in Q4 2024 and has held it in 6 quarters since.
Caitong International Asset Management's AngioDynamics position peaked at $4.08K in Q1 2025.
37 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.